Analysis of extracellular vesicles using magnetic nanoparticles in blood of patients with acute coronary syndrome

M. S. Vagida, A. Arakelyan, A. M. Lebedeva, Jean-Charles B. Grivel, A. V. Shpektor, E. Yu Vasilieva, L. B. Margolis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Extracellular vesicles (EVs) are released from various cell types and play an important role in intercellular interactions. In our study, we investigated abundance of individual EVs in patients with acute forms of ischemic heart disease. Previously, we developed an approach for individual analysis of EVs conjugated with magnetic nanoparticles (MNPs), which was applied in the current study for analyzing phenotypic composition of EVs (by staining for markers CD31, CD41a, and CD63). EVs were isolated using fluorescently labeled MNPs containing anti-CD31, CD41a, or CD63 antibodies and analyzed by combining fluorescently labeled anti-CD41a and CD63, CD31 and CD63, or CD41a and CD31 antibodies, respectively. EVs were analyzed in 30 individuals: 17 healthy volunteers and 13 patients with acute coronary syndrome (ACS). Six and seven ACS patients were with acute myocardial infarction and unstable angina, respectively. It was found that patients with ACS and healthy volunteers contained a dominant subset of EVs expressing surface CD41a antigen, suggesting that they originated from platelets. In addition, the total number of EVs isolated using either of the surface markers examined in our study was higher in patients with ACS compared to healthy volunteers. The subgroup of patients with acute myocardial infarction was found to contain significantly higher number of blood EVs compared to the control group. Moreover, increased number of EVs in patients with ACS is mainly due to the increased number of EVs in the subset of EVs bearing CD41a. By analyzing individual EVs, we found that plasma of patients with ACS, particularly upon developing of myocardial infarction, contained dominant platelet-derived EVs fraction, which may reflect activation of platelets in such patients.

Original languageEnglish
Pages (from-to)382-391
Number of pages10
JournalBiochemistry (Moscow)
Volume81
Issue number4
DOIs
Publication statusPublished - 1 Apr 2016
Externally publishedYes

Fingerprint

Acute Coronary Syndrome
Platelets
Nanoparticles
Blood
Bearings (structural)
Antibodies
Surface Antigens
Chemical activation
Plasmas
Healthy Volunteers
Chemical analysis
Myocardial Infarction
Extracellular Vesicles
Blood Platelets
Unstable Angina
Platelet Activation
Myocardial Ischemia

Keywords

  • acute coronary syndrome
  • extracellular vesicles
  • flow cytometry
  • platelets

ASJC Scopus subject areas

  • Biochemistry

Cite this

Vagida, M. S., Arakelyan, A., Lebedeva, A. M., Grivel, J-C. B., Shpektor, A. V., Vasilieva, E. Y., & Margolis, L. B. (2016). Analysis of extracellular vesicles using magnetic nanoparticles in blood of patients with acute coronary syndrome. Biochemistry (Moscow), 81(4), 382-391. https://doi.org/10.1134/S0006297916040088

Analysis of extracellular vesicles using magnetic nanoparticles in blood of patients with acute coronary syndrome. / Vagida, M. S.; Arakelyan, A.; Lebedeva, A. M.; Grivel, Jean-Charles B.; Shpektor, A. V.; Vasilieva, E. Yu; Margolis, L. B.

In: Biochemistry (Moscow), Vol. 81, No. 4, 01.04.2016, p. 382-391.

Research output: Contribution to journalArticle

Vagida, M. S. ; Arakelyan, A. ; Lebedeva, A. M. ; Grivel, Jean-Charles B. ; Shpektor, A. V. ; Vasilieva, E. Yu ; Margolis, L. B. / Analysis of extracellular vesicles using magnetic nanoparticles in blood of patients with acute coronary syndrome. In: Biochemistry (Moscow). 2016 ; Vol. 81, No. 4. pp. 382-391.
@article{e024a9b1388947acbfe0859a37cadd88,
title = "Analysis of extracellular vesicles using magnetic nanoparticles in blood of patients with acute coronary syndrome",
abstract = "Extracellular vesicles (EVs) are released from various cell types and play an important role in intercellular interactions. In our study, we investigated abundance of individual EVs in patients with acute forms of ischemic heart disease. Previously, we developed an approach for individual analysis of EVs conjugated with magnetic nanoparticles (MNPs), which was applied in the current study for analyzing phenotypic composition of EVs (by staining for markers CD31, CD41a, and CD63). EVs were isolated using fluorescently labeled MNPs containing anti-CD31, CD41a, or CD63 antibodies and analyzed by combining fluorescently labeled anti-CD41a and CD63, CD31 and CD63, or CD41a and CD31 antibodies, respectively. EVs were analyzed in 30 individuals: 17 healthy volunteers and 13 patients with acute coronary syndrome (ACS). Six and seven ACS patients were with acute myocardial infarction and unstable angina, respectively. It was found that patients with ACS and healthy volunteers contained a dominant subset of EVs expressing surface CD41a antigen, suggesting that they originated from platelets. In addition, the total number of EVs isolated using either of the surface markers examined in our study was higher in patients with ACS compared to healthy volunteers. The subgroup of patients with acute myocardial infarction was found to contain significantly higher number of blood EVs compared to the control group. Moreover, increased number of EVs in patients with ACS is mainly due to the increased number of EVs in the subset of EVs bearing CD41a. By analyzing individual EVs, we found that plasma of patients with ACS, particularly upon developing of myocardial infarction, contained dominant platelet-derived EVs fraction, which may reflect activation of platelets in such patients.",
keywords = "acute coronary syndrome, extracellular vesicles, flow cytometry, platelets",
author = "Vagida, {M. S.} and A. Arakelyan and Lebedeva, {A. M.} and Grivel, {Jean-Charles B.} and Shpektor, {A. V.} and Vasilieva, {E. Yu} and Margolis, {L. B.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1134/S0006297916040088",
language = "English",
volume = "81",
pages = "382--391",
journal = "Biochemistry (Moscow)",
issn = "0006-2979",
publisher = "Maik Nauka-Interperiodica Publishing",
number = "4",

}

TY - JOUR

T1 - Analysis of extracellular vesicles using magnetic nanoparticles in blood of patients with acute coronary syndrome

AU - Vagida, M. S.

AU - Arakelyan, A.

AU - Lebedeva, A. M.

AU - Grivel, Jean-Charles B.

AU - Shpektor, A. V.

AU - Vasilieva, E. Yu

AU - Margolis, L. B.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Extracellular vesicles (EVs) are released from various cell types and play an important role in intercellular interactions. In our study, we investigated abundance of individual EVs in patients with acute forms of ischemic heart disease. Previously, we developed an approach for individual analysis of EVs conjugated with magnetic nanoparticles (MNPs), which was applied in the current study for analyzing phenotypic composition of EVs (by staining for markers CD31, CD41a, and CD63). EVs were isolated using fluorescently labeled MNPs containing anti-CD31, CD41a, or CD63 antibodies and analyzed by combining fluorescently labeled anti-CD41a and CD63, CD31 and CD63, or CD41a and CD31 antibodies, respectively. EVs were analyzed in 30 individuals: 17 healthy volunteers and 13 patients with acute coronary syndrome (ACS). Six and seven ACS patients were with acute myocardial infarction and unstable angina, respectively. It was found that patients with ACS and healthy volunteers contained a dominant subset of EVs expressing surface CD41a antigen, suggesting that they originated from platelets. In addition, the total number of EVs isolated using either of the surface markers examined in our study was higher in patients with ACS compared to healthy volunteers. The subgroup of patients with acute myocardial infarction was found to contain significantly higher number of blood EVs compared to the control group. Moreover, increased number of EVs in patients with ACS is mainly due to the increased number of EVs in the subset of EVs bearing CD41a. By analyzing individual EVs, we found that plasma of patients with ACS, particularly upon developing of myocardial infarction, contained dominant platelet-derived EVs fraction, which may reflect activation of platelets in such patients.

AB - Extracellular vesicles (EVs) are released from various cell types and play an important role in intercellular interactions. In our study, we investigated abundance of individual EVs in patients with acute forms of ischemic heart disease. Previously, we developed an approach for individual analysis of EVs conjugated with magnetic nanoparticles (MNPs), which was applied in the current study for analyzing phenotypic composition of EVs (by staining for markers CD31, CD41a, and CD63). EVs were isolated using fluorescently labeled MNPs containing anti-CD31, CD41a, or CD63 antibodies and analyzed by combining fluorescently labeled anti-CD41a and CD63, CD31 and CD63, or CD41a and CD31 antibodies, respectively. EVs were analyzed in 30 individuals: 17 healthy volunteers and 13 patients with acute coronary syndrome (ACS). Six and seven ACS patients were with acute myocardial infarction and unstable angina, respectively. It was found that patients with ACS and healthy volunteers contained a dominant subset of EVs expressing surface CD41a antigen, suggesting that they originated from platelets. In addition, the total number of EVs isolated using either of the surface markers examined in our study was higher in patients with ACS compared to healthy volunteers. The subgroup of patients with acute myocardial infarction was found to contain significantly higher number of blood EVs compared to the control group. Moreover, increased number of EVs in patients with ACS is mainly due to the increased number of EVs in the subset of EVs bearing CD41a. By analyzing individual EVs, we found that plasma of patients with ACS, particularly upon developing of myocardial infarction, contained dominant platelet-derived EVs fraction, which may reflect activation of platelets in such patients.

KW - acute coronary syndrome

KW - extracellular vesicles

KW - flow cytometry

KW - platelets

UR - http://www.scopus.com/inward/record.url?scp=84969795455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969795455&partnerID=8YFLogxK

U2 - 10.1134/S0006297916040088

DO - 10.1134/S0006297916040088

M3 - Article

VL - 81

SP - 382

EP - 391

JO - Biochemistry (Moscow)

JF - Biochemistry (Moscow)

SN - 0006-2979

IS - 4

ER -